Appendix B: Family History Workshop Agenda

A Report for the
Office of Genomics and Disease Prevention
National Center for Environmental Health
Centers for Disease Control and Prevention
Prepared by Susan Baker Toal, MPH
August 19, 2002

• Back to the Main Document
• Appendix A: Participant Roster
• Appendix B: Agenda
• Appendix C: Worksheets
• Appendix D: Selected Bibliography

a. Presentation – 20 minutes
b. Discussion – 10 minutes
9:45 a.m.Family History of Colorectal Cancer……………………………… Bob Millikan
University of North Carolina, Chapel Hill
a. Presentation – 20 minutes
b. Discussion – 10 minutes
10:15 a.m.BREAK10:30 a.m.Can Family History of Type-2 Diabetes to be used…………Karen Edwards
as a Tool for Public Health? University of Washington
a. Presentation – 20 minutes
b. Discussion – 10 minutes
11:00 a.m.Family History as a Potential Tool in Asthma Prevention…..Wylie Burke
University of Washington
a. Presentation – 20 minutes
b. Discussion – 10 minutes
11:30 a.m.LUNCHSESSION I. ANALYTIC VALIDITY
Moderator: Robin Bennett, University of Michigan1:00 p.m.Documenting the Family Health History: An…………. Kristen Peterson Oehlke
Overview of Available Tools Office of Genomics and Disease Prevention, CDC1:15 p.m.Family History as a Tool for Risk Assessment in………….. Hoda Anton-Culver
Public Health Research and Practice and In Preventive Medicine University of California, Irvine1:35 p.m.Group Discussion – IdentifyKnowledge Gaps and Describe Studies Needed to Assess Analytic ValiditySESSION II. CLINICAL VALIDITY
Moderator: Marta Gwinn, Office of Genomics and Disease Prevention, CDC2:15 p.m.Family History Collection and Pedigree Analysis……………… Maren Scheuner2:35 p.m.Family History of Cancer and Cancer Screening in the………. Ingrid Hall
General Population National Center for Chronic Disease Prevention and Health Promotion, CDC2:45 p.m.Do Americans Know Their Family History of ……….. Joelyn Tonkin
Asthma and Heart Disease? Office of Genomics and Disease Prevention, CDC3:00 p.m.BREAK3:15 p.m.Group Discussion – Identify Knowledge Gaps and Describe Studies Needed to Assess Clinical ValiditySESSION III.A CLINICAL UTILITY
Moderator: Christopher Friedrich, University of Mississippi Medical Center4:00 p.m.Population Versus High-Risk Prevention Strategies: ……….. Steven Hunt
Do We Need to Choose? University of Utah4:20 p.m.Association Between Family History of Colorectal Cancer……….. Jill Morris
and Preventive Health Behaviors in Women – United States, 1997
Office of Genomics and Disease Prevention, CDC4:35 p.m.Using Decision Analytic Method to Assess the Utilityof Family History for Public Health and Preventive Medicine……….. Anupam Tyagi
National Center for Chronic Disease and Prevention and Health Promotion, CDC4:50 p.m.Discussion5:15 p.m.ADJOURN